🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
The primary objective of the study is to compare sacituzumab tirumotecan co...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Start Date
2023-12-15
Trial ID
NCT06170788
Treatments Being Tested
This is a First-in-Human, Phase 1, Dose-Escalation and Dose-Expansion study...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2024-12-11
Trial ID
NCT06724016
Treatments Being Tested
The purpose was to evaluate the efficacy and safety of the combination of c...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2020-01-22
Trial ID
NCT04139317
Treatments Being Tested
Comparing the PK similarity of BAT3306 and Keytruda; in NSCLC participants ...
Status
Recruiting
Location
Union Hospital Tongji Medical College Huazhong University of Science & Technology
Start Date
2025-10-14
Trial ID
NCT07180862
Treatments Being Tested
The goal of this clinical trial is to compare the safety and efficacy (how ...
Status
Active Not Recruiting
Location
St. Joseph Heritage Healthcare
Start Date
2021-10-27
Trial ID
NCT05117242
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and effic...
Status
Completed
Location
Levine Cancer Institute
Start Date
2017-05-01
Trial ID
NCT03056001
Treatments Being Tested
This is a multicenter, randomized, double-blind, controlled Phase 2/3 trial...
Status
Active Not Recruiting
Location
Exelixis Clinical Site #2
Start Date
2024-06-07
Trial ID
NCT06082167
Treatments Being Tested
This study will examine the safety, pharmacokinetics, and efficacy of escal...
Status
Terminated
Location
City of Hope National Medical Center ( Site 0004)
Start Date
2019-03-18
Trial ID
NCT03833427
Treatments Being Tested